Loesche, C; Kolbinger, F; Valentin, MA; Jarvis, P; Cheng, Y; Bruin, G; Polus, F; Aigner, B; Bodenlenz, M; Sinner, F; Pieber, TR; Patel, DD.
beta-defensin-2 (BD-2) responds to a single dose of anti-IL-17A secukinumab in different skin layers of psoriatic patients within days
EXP DERMATOL. .. 2016; 25: 37-38.-2nd Inflammatroy Skin Disease Summit; NOV 16-19, 2016; New York, NY.
[Poster]
Web of Science